Загрузка...
The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension
1 In a double-blind, placebo controlled, crossover study 12 patients with essential hypertension received single doses of 5, 10 and 20 mg of cilazapril. 2 Peak plasma levels of cilazaprilat and the 24 h areas under curve were directly proportional to dose. 3 The elimination half-life during the firs...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1989
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1379756/ https://ncbi.nlm.nih.gov/pubmed/2548553 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|